New hope for hemophilia patients whose bodies fight treatment
NCT ID NCT04023019
Summary
This study aims to understand the best ways to treat people with hemophilia A whose immune systems have developed 'inhibitors' that block standard treatments. Researchers will observe 120 male participants for up to 5 years as they receive different combinations of immune tolerance therapy and newer medications to control bleeding. The goal is to compare how well these approaches work to reduce inhibitors, control bleeds, and improve safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arthur M. Blank Hospital
RECRUITINGAtlanta, Georgia, 30329, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
HZRM Hämophilie-Zentrum Rhein Main
RECRUITINGMörfelden-Walldorf, 64546, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.